Login / Signup

Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review.

Stan R W WijnMaroeska M RoversLy H LeMichail BeliasJeroen HooglandJoanna IntHoutThomas DebrayJohannes B Reitsma
Published in: BMJ open (2019)
Almost half of the organisations included in this scoping review provided guidance on subgroup effect research in their guidelines. However, there were large differences between organisations in the amount and level of detail of their guidance. Effort is required to translate and integrate research findings on subgroup analysis to practical guidelines for decision making and to reduce the differences between organisations and organisation types.
Keyphrases
  • decision making
  • phase iii
  • clinical practice
  • healthcare
  • clinical trial
  • study protocol
  • double blind
  • placebo controlled